WillItSurvive
Pharma and healthcare groups · Philippines

Unilab (United Laboratories)

unilab.com.ph ↗

Philippines' top drugmaker, selling OTC staples like Biogesic and Neozep nationwide.

Hard to displace
Assessed 26 July 2026 · Evidence as of 26 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 26 July 2026 · Checkable from July 2026 · Every call on the record Checkpoint: Manila Times Health Forum, where DOH/FDA drug-pricing policy gets discussed
The call

Unilab's edge sits in trucks, pharmacy shelves, and brand names Filipinos have bought for decades, not in software or algorithms.

Unilab makes over-the-counter medicines like Biogesic and Neozep that Filipinos buy without a prescription. It is hard to replace because it owns its own delivery trucks and stores, has trusted brand names going back decades, and makes drugs locally with government approval, while big global companies like Pfizer and GlaxoSmithKline focus on prescription drugs and do not have those same local advantages. The one thing that could hurt Unilab is if the Philippine government pushes medicine prices down through new health laws, which would squeeze the company's profits even if it keeps its market lead.

Why
01
AI pressure: None apparent. AI tools like Darwinbox run Unilab's HR, not its drug sales; OTC medicine buying stays a physical, pharmacy-counter act. Could AI do the core job? Unlikely.
02
Bigger players: Pfizer, GSK, Sanofi, J&J, Novartis, Abbott. Multinationals sell prescription drugs in the Philippines but hold single-digit OTC share versus Unilab's roughly 25%. Could a giant copy it? No, they are blocked.
03
What protects it. Unilab owns its own distribution (First Pioneer), 80 years of household brand trust, and local GMP plants multinationals don't replicate here.
What would change this call
DOH/FDA Philippines issues price caps or generic-substitution mandates on OTC drugs. Would show regulatory pressure directly compressing Unilab's margins.
IQVIA or PCC publishes updated Philippine pharma market-share data (post-2016). Would confirm whether Unilab's ~25% share has eroded to rivals.
Pascual Laboratories or Natrapharm launches a major distribution or brand expansion in OTC. Would show a domestic rival actively contesting Unilab's mass-market turf.
Key numbers
  • Unilab holds ~25.1% Philippine pharma market share (2016)
  • Pfizer holds ~6.4% share in the same market (2016)
  • Unilab founded January 1, 1945 as a small drugstore (1945)
Named risks
  • Potential Philippine government price caps or generic-substitution mandates on branded OTC medicines. Severity: high
  • Execution risk from multi-year SAP ECC to S/4HANA Cloud migration announced May 2025. Severity: medium
  • Leadership transition to Clinton Campos Hess (2025) still unproven over multi-year strategy execution. Severity: medium
  • Company financials remain undisclosed since Unilab is private, limiting external verification. Severity: low
  • Status of a 2021-announced COVID-19 vaccine plant remains unconfirmed as of 2026. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Pfizerlosing toHeld only ~6.4% Philippine share vs Unilab's ~25.1% per 2016 IQVIA/MIMS data cited by PCC
GlaxoSmithKlinelosing toHeld only ~4.8% Philippine share vs Unilab's ~25.1% per 2016 IQVIA/MIMS data cited by PCC
Pascual Laboratorieslosing toSold Pharex brand to Unilab in 2016; remains a smaller domestic rival
Sanofi, J&J, Novartis, AstraZeneca, Abbott, Boehringer IngelheimcontestingCompete mainly in prescription/ethical drug segment, not Unilab's dominant OTC turf, per PCC 2020 industry paper
Questions people ask
Is Unilab profitable in 2025?
Unilab does not publicly disclose audited financials as a private company. A 2024 case study citing IMS-type data put Philippine sales near PHP 27.3 billion with about 22% market share, and Euromonitor's November 2025 report confirms it remains the clear consumer-health category leader in the Philippines.
Who owns Unilab (United Laboratories)?
Unilab is privately held by the Campos-Hess family, founded by Jose Yao Campos in 1945. Leadership formally passed from Jocelyn Campos Hess to her son Clinton Campos Hess, who became Group Chairman, President and CEO around the company's 80th anniversary event on May 21, 2025.
Could AI replace Unilab's business?
No. Unilab's moat is physical manufacturing, GMP-certified plants, owned distribution via First Pioneer Distribution, and 80 years of consumer brand trust in products like Biogesic. As of May 2025 it adopted AI-powered SAP S/4HANA and Darwinbox HR tools, but only for back-office efficiency, not core production or distribution.
Who is Unilab's biggest competitor?
Multinationals like Pfizer and GlaxoSmithKline compete in prescription drugs but held only about 6.4% and 4.8% Philippine market share respectively versus Unilab's roughly 25.1% as of 2016 IQVIA/MIMS data, per a Philippine Competition Commission paper; domestically, Pascual Laboratories is a smaller rival.
Does Unilab operate outside the Philippines?
Yes, through its 92.13% stake in PT Darya-Varia Laboratoria Tbk, a publicly listed Indonesian pharmaceutical company held via Blue Sphere Singapore Pte Ltd; Darya-Varia announced an Eisai Indonesia gastrointestinal partnership and an ASKI AI/IoT medical device venture around June 18, 2026.
What is Unilab's flagship product?
Biogesic, a paracetamol tablet priced at just a few pesos, is Unilab's best-known flagship brand, alongside Alaxan, Neozep, Enervon, Ceelin, Decolgen, Solmux and Conzace, forming the core of its OTC portfolio that has led the Philippine consumer-health market for decades.
Timeline
  • 2026-07-18Presents quality/regulatory framework at Manila Times Health Forum amid drug-price policy discussion
  • 2026-06-18Subsidiary Darya-Varia announces Eisai Indonesia GI partnership and ASKI AI/IoT medical device venture
  • 2026-03-03LinkedIn company page shows 4,808 employees and 382,909 followers
  • 2025-10-28Darwinbox AI-native HCM platform rollout for HR highlighted in case study
  • 2025-05-28Announces RISE with SAP on AWS to migrate from SAP ECC to S/4HANA Cloud
  • 2025-05-2180th-anniversary event; Clinton Campos Hess becomes Group Chairman, President and CEO
  • 2025-05-19Jocelyn Campos Hess transitions to Chairman Emeritus
  • 2023-01Unilab Center for Health Policy (UCHP) formally launched
  • 2016-01Acquires Pharex brand from Pascual Laboratories
  • 1945-01-01Founded as a small drugstore in Binondo, Manila by Jose Yao Campos and Mariano K. Tan
Revision history
26 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Vertex PharmaceuticalsTenet HealthcareIntuitive Surgical
More in Pharma and healthcare groups →
Sources